Search Results
103 results
Your search is now limited to «FDA Actions» expert search.
Business Wire 02/20/2019 16:10
FDA approval of pembrolizumab in the adjuvant setting is based on results from the KEYNOTE-054 trial.
More from Business Wire:
Activist Post 02/20/2019 14:56
Attorney Alan Phillips provided the following charts, which ought to cause “shock and awe” among parents, health departments everywhere, and even at HHS-CDC-FDA if they are open to factual science, not consensus fraudulent science.
More from Activist Post:
Upadacitinib, an investigational once-daily oral JAK1-selective inhibitor, is being studied for the treatment of adult patients with moderate to severe rheumatoid arthritis[1-8]. The New Drug Application (NDA) is supported by data from the global upadaci...
More from Healthcare Sales & Marketing Network:
WN.com 02/19/2019 10:07
NORTH CHICAGO, Ill., Feb. 19, 2019/PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, has announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review its New Drug Application (NDA) for upadacitinib for the treatment of adult patients with moderate to severe rheumatoid arthritis.
More from WN.com:
PR Newswire 02/12/2019 10:12
That means accountability throughout the supply chain, including important oversight by the FDA to ensure every entity within the chain is complying with the law.
More from PR Newswire:
Healio News 02/12/2019 09:43
Among the top stories in infectious disease last week were the FDA’s acceptance of a new drug application for two Merck antibacterial agents meant to treat complicated UTIs and intra-abdominal infections and President Donald J. Trump’s announcement of a goal of ending the HIV epidemic in the US by 2030 ...
More from Healio News:
GlobeNewswire 02/12/2019 01:07
Media Release Copenhagen, Denmark, February 12, 2019.
More from GlobeNewswire:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications